Europe will receive the vaccines adapted to Omicron variants a few days after the approval, European Parliament member Peter Liese said recently.
The European Medicines Agency (EMA) this week approved the Moderna and Pfizer-BioNTech vaccines adapted for the BA.1 variant of Omicron, as well as the original strain that first appeared in China.
Moderna will supply the European Union with 70 million doses of the vaccine in the first two months, with 8 to 11 million expected to be available as early as the first week of September, and Germany scheduled to receive 4 million doses in the first two weeks after approval, Liese stated in a press release, transmits Reuters.
Germany receives 29 million doses of vaccine
Meanwhile, up to 29 million doses of the vaccine made by Pfizer and BioNTech are expected to be delivered in September in Germany alone, including 10 million in the first two weeks after approval, he added.
“We cannot comment on future deliveries,” a European Commission spokesman said.
Representatives for Moderna, Pfizer and BioNTech could not be reached.